Please use this identifier to cite or link to this item: https://doi.org/10.1007/s40268-019-00287-y
DC FieldValue
dc.titleUse of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort Study
dc.contributor.authorYeo, S.-H.
dc.contributor.authorKong, K.H.
dc.contributor.authorLim, D.C.-K.
dc.contributor.authorYau, W.-P.
dc.date.accessioned2021-12-29T04:04:38Z
dc.date.available2021-12-29T04:04:38Z
dc.date.issued2019
dc.identifier.citationYeo, S.-H., Kong, K.H., Lim, D.C.-K., Yau, W.-P. (2019). Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort Study. Drugs in R and D 19 (4) : 367-379. ScholarBank@NUS Repository. https://doi.org/10.1007/s40268-019-00287-y
dc.identifier.issn11745886
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/212228
dc.description.abstractPurpose: The aim of this study was to examine the association between selective serotonin reuptake inhibitor (SSRI) therapy and rehabilitation outcomes, specifically disability and quality of life (QOL), in a real-world setting of multi-ethnic Asian patients with first-ever stroke. Methods: In this prospective observational pilot cohort study, we included patients with first-ever stroke admitted to two inpatient rehabilitation centres in Singapore between January and July 2018. Outcomes were measured using Functional Independence Measure (FIM)-motor scale, modified Barthel Index (MBI) and the Stroke and Aphasia Quality of Life Scale-39 generic (SAQOL-39g) questionnaire. Linear regression was used to assess the association between SSRI therapy and outcomes. Regression coefficients and 95% confidence intervals (CIs) were reported. Results: Among 57 patients included for analyses, 38.6% received SSRIs. Although SSRI therapy was significantly associated with gains in MBI (coefficient 11.35; 95% CI 0.21–22.50) and SAQOL-39g overall score (coefficient 0.45; 95% CI 0.05–0.85) based on simple linear regression, no significant association between SSRI therapy and any of the investigated outcomes was found after adjustment for confounders. However, an increase in the mean number of physiotherapy and occupational therapy (PT/OT) sessions per day significantly improved FIM-motor (coefficient 16.86; 95% CI 2.64–31.07) and MBI (coefficient 22.79; 95% CI 2.35–43.23) scores. Conclusion: SSRI therapy did not improve disability and QOL in multi-ethnic Asian patients with first-ever stroke undergoing rehabilitation. © 2019, The Author(s).
dc.publisherAdis
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScopus OA2019
dc.typeArticle
dc.contributor.departmentDEPT OF PHARMACY
dc.description.doi10.1007/s40268-019-00287-y
dc.description.sourcetitleDrugs in R and D
dc.description.volume19
dc.description.issue4
dc.description.page367-379
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1007_s40268-019-00287-y.pdf889.84 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

2
checked on Jan 25, 2023

Page view(s)

76
checked on Jan 26, 2023

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons